Skip to content
Wednesday, 18 November 2026
Inspire.News

Unveiling truth, one story at a time

Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital

Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital
Image: South China Morning Post

Hong Kong needs more “patient capital” and more talent capable of commercialising research and development to sustain the city’s biotechnology ecosystem, according to a senior executive at a local biotech start-up. Yicura BioMed, based in the Hong Kong Science Park, is heading towards an initial public offering (IPO) in the city as soon as practicable, CEO Xian Jin said in…

Full story

Continue reading this story on South China Morning Post, the publisher that reported it.

Read the full story at South China Morning Post ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business · Asian

See all